CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
9.57
-0.07 (-0.73%)
Nov 21, 2024, 2:58 PM EST - Market open
CervoMed Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$53.67
Upside
+460.82%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +255.28% | Nov 18, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $55 | Strong Buy | Maintains | $55 | +474.71% | Nov 14, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $55 | Strong Buy | Initiates | $55 | +474.71% | Sep 18, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $35 | Buy | Initiates | $35 | +265.73% | Jul 26, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $65 | Strong Buy | Maintains | $65 | +579.21% | Jul 25, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $63 | Strong Buy | Initiates | $63 | +558.31% | Jul 8, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +631.45% | May 29, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $50 → $65 | Strong Buy | Maintains | $50 → $65 | +579.21% | Apr 8, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +422.47% | Feb 15, 2024 |